These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

725 related articles for article (PubMed ID: 20060064)

  • 1. Increased incidence of small intestinal bacterial overgrowth during proton pump inhibitor therapy.
    Lombardo L; Foti M; Ruggia O; Chiecchio A
    Clin Gastroenterol Hepatol; 2010 Jun; 8(6):504-8. PubMed ID: 20060064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton pump inhibitor therapy use does not predispose to small intestinal bacterial overgrowth.
    Ratuapli SK; Ellington TG; O'Neill MT; Umar SB; Harris LA; Foxx-Orenstein AE; Burdick GE; Dibaise JK; Lacy BE; Crowell MD
    Am J Gastroenterol; 2012 May; 107(5):730-5. PubMed ID: 22334250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between chronic use of proton pump inhibitors and small- intestinal bacterial overgrowth assessed using lactulose hydrogen breath tests.
    Fujiwara Y; Watanabe T; Muraki M; Yamagami H; Tanigawa T; Shiba M; Tominaga K; Arakawa T
    Hepatogastroenterology; 2015; 62(138):268-72. PubMed ID: 25916046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small intestinal bacterial overgrowth produces symptoms in irritable bowel syndrome which are improved by rifaximin. A pilot study.
    Moraru IG; Portincasa P; Moraru AG; Diculescu M; Dumitraşcu DL
    Rom J Intern Med; 2013; 51(3-4):143-7. PubMed ID: 24620626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical features of irritable bowel syndrome with small intestinal bacterial overgrowth and a preliminary study of effectiveness of Rifaximin].
    Liu ZJ; Wei H; Duan LP; Zhu SW; Zhang L; Wang K
    Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(24):1896-902. PubMed ID: 27373356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of small intestinal bacterial overgrowth testing in irritable bowel syndrome patients: clinical profiles and effects of antibiotic trial.
    Majewski M; McCallum RW
    Adv Med Sci; 2007; 52():139-42. PubMed ID: 18217406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small intestinal bacterial overgrowth is associated to symptoms in irritable bowel syndrome. Evidence from a multicentre study in Romania.
    Moraru IG; Moraru AG; Andrei M; Iordache T; Drug V; Diculescu M; Portincasa P; Dumitrascu DL
    Rom J Intern Med; 2014; 52(3):143-50. PubMed ID: 25509557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton pump inhibitors, irritable bowel syndrome, and small intestinal bacterial overgrowth: coincidence or Newton's third law revisited?
    Chey WD; Spiegel B
    Clin Gastroenterol Hepatol; 2010 Jun; 8(6):480-2. PubMed ID: 20304096
    [No Abstract]   [Full Text] [Related]  

  • 9. Chronic prostatitis and small intestinal bacterial overgrowth: effect of rifaximin.
    Weinstock LB; Geng B; Brandes SB
    Can J Urol; 2011 Aug; 18(4):5826-30. PubMed ID: 21854715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of long-term PPI treatment on producing bowel symptoms and SIBO.
    Compare D; Pica L; Rocco A; De Giorgi F; Cuomo R; Sarnelli G; Romano M; Nardone G
    Eur J Clin Invest; 2011 Apr; 41(4):380-6. PubMed ID: 21128930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breath tests in the diagnosis of small intestinal bacterial overgrowth in patients with irritable bowel syndrome in comparison with quantitative upper gut aspirate culture.
    Ghoshal UC; Srivastava D; Ghoshal U; Misra A
    Eur J Gastroenterol Hepatol; 2014 Jul; 26(7):753-60. PubMed ID: 24849768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of the methodological and clinical validity of the combined lactulose hydrogen breath test with scintigraphic oro-cecal transit test for diagnosing small intestinal bacterial overgrowth in IBS patients.
    Zhao J; Zheng X; Chu H; Zhao J; Cong Y; Fried M; Fox M; Dai N
    Neurogastroenterol Motil; 2014 Jun; 26(6):794-802. PubMed ID: 24641100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis: proton pump inhibitors moderately increase the risk of small intestinal bacterial overgrowth.
    Su T; Lai S; Lee A; He X; Chen S
    J Gastroenterol; 2018 Jan; 53(1):27-36. PubMed ID: 28770351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A proof-of-concept study showing antibiotics to be more effective in irritable bowel syndrome with than without small-intestinal bacterial overgrowth: a randomized, double-blind, placebo-controlled trial.
    Ghoshal UC; Srivastava D; Misra A; Ghoshal U
    Eur J Gastroenterol Hepatol; 2016 Mar; 28(3):281-9. PubMed ID: 26731696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small intestinal bacterial overgrowth in rosacea: clinical effectiveness of its eradication.
    Parodi A; Paolino S; Greco A; Drago F; Mansi C; Rebora A; Parodi A; Savarino V
    Clin Gastroenterol Hepatol; 2008 Jul; 6(7):759-64. PubMed ID: 18456568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacterial overgrowth and irritable bowel syndrome: unifying hypothesis or a spurious consequence of proton pump inhibitors?
    Spiegel BM; Chey WD; Chang L
    Am J Gastroenterol; 2008 Dec; 103(12):2972-6. PubMed ID: 19086951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short article: Risk of small intestinal bacterial overgrowth with chronic use of proton pump inhibitors in children.
    Cares K; Al-Ansari N; Macha S; Zoubi N; Zaghloul H; Thomas R; Lalinsky P; El-Baba M
    Eur J Gastroenterol Hepatol; 2017 Apr; 29(4):396-399. PubMed ID: 28030512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Estimation of small intestinal bacterial overgrowth in patients with constipation and diarrhea irritable bowel syndrome].
    Łokieć K; Klupińska G; Walecka-Kapica E; Błońska A
    Pol Merkur Lekarski; 2014 May; 36(215):307-10. PubMed ID: 24964506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microscopic colitis and small intestinal bacterial overgrowth--diagnosis behind the irritable bowel syndrome?
    Stoicescu A; Andrei M; Becheanu G; Stoicescu M; Nicolaie T; Diculescu M
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(3):766-72. PubMed ID: 23272525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small intestinal bacterial overgrowth in patients suffering from scleroderma: clinical effectiveness of its eradication.
    Parodi A; Sessarego M; Greco A; Bazzica M; Filaci G; Setti M; Savarino E; Indiveri F; Savarino V; Ghio M
    Am J Gastroenterol; 2008 May; 103(5):1257-62. PubMed ID: 18422815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.